I'm doing animal study using NCr nude mice to determine the anti-tumour activity of BVD-523 (Ulixertinib). As most of the literature reviews reported on oral administration and intravenous injection of BVD-523 in mice, I'm unsure about the dose to use as Intraperitoneal injection. Is there any recommended research article that I could refer regarding this experiment?

Thanks!

Similar questions and discussions